Research

RESEARCH

 

Recent Publications

Greenstein JI: Diffuse dermatophytosis occurring on dimethylfumarate therapy Multiple Sclerosis Journal 2018:24(7) 999-1001

Editorial comment on the paper: Correale J: New fungal infections associated with disease-modifying treatments in MS Multiple Sclerosis Journal 2018: 24(7) 1004-1006.

Cunningham TJ, Greenstein JI, Yao L, Fischer I, Connors T. Heptamer Peptide Disassembles Native Amyloid in Human Plasma Through Heat Shock Protein 70.

 
 

All Publications

Cunningham, TJ, Oetinger, M, Blankenhorn EP, Greenstein, JI. Secreted Phospholipase A2 activity in experimental allergic encephalomyelitis and multiple sclerosis. Journal of Neuroinflammation 2006; 3:26

Herndon RM, Greenstein JI. Multiple Sclerosis and Demyelinating Diseases. In: Herndon RM. (Ed) Handbook of Neurologic Rating Scales. 2nd Ed. 2007.

Greenstein JI. Current concepts of the cellular and molecular pathophysiology of Multiple Sclerosis. Developmental Neurobiology 2008; 67:1248-1265.

Cunningham, TJ, Greenstein, JI et al. Uncompetitive Phospholipase A2 inhibition by CHEC sequences including oral treatment of experimental autoimmune myeloencephalitis. The Open Enzyme Inhibition Journal 2009; 2:1-7.

Greenstein JI. Oral disease modifying therapy for MS: Important considerations. Practical Neurology 2011; 10:36 41.

Greenstein JI. Immunemodulation induced by Natalizumab therapy in Multiple Sclerosis. Academy of Neurology Annual Meeting April, 2014

Greenstein JI, Cunningham TJ. Neuroprotective, Anti-inflammatory and Immune Tolerizing properties of peptides derived from Diffusion Survival Evasion Protein (DSEP)/Dermcidin. Academy of Neurology Annual Meeting April, 2014.

Cunningham TJ, Greenstein JI, Loewenstein J, Degermentzidis. Anti-inflammatory peptide regulates supply of heat shock protein 70 monomers: Implications for aging and aging-related disease. Rejuvenation Research. 2015. 18(2):136-144.

Buckle G, Bandari BD, Greenstein JI, et al. Effect of delayed-release Dimethyl Fumarate on lymphocyte subsets in patients with Relapsing Multiple Sclerosis: Interim analysis of REALIZE. Consortium of Multiple Sclerosis Centers. 2016 Annual Meeting.

Buckle G, Bandari BD, Greenstein JI, et al. Effect of delayed-release Dimethyl Fumarate on lymphocyte subsets in patients with Relapsing Multiple Sclerosis: A retrospective, multicenter, observational study (REALIZE). EP1495 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis.

Greenstein JI: Diffuse dermatophytosis occurring on dimethylfumarate therapy Multiple Sclerosis Journal 2018:24(7) 999-1001

Editorial comment on the paper: Correale J: New fungal infections associated with disease-modifying treatments in MS Multiple Sclerosis Journal 2018: 24(7) 1004-1006.

Cunningham TJ, Greenstein JI, Yao L, Fischer I, Connors T. Heptamer Peptide Disassembles Native Amyloid in Human Plasma Through Heat Shock Protein 70.

FIND, STOP, CURE MS